References
- 1991, National Asthma Education and Prevention Program Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma
- Global Initiative for Asthma; Global Strategy for Asthma Management and Prevention. National Institutes of Health, National Heart Lung and Blood Institute, revised 2002. NIH publication 02–3659
- Liard R, Leynaert B, Zureik M, Beguin F-X, Neukirch F. Using global initiative for asthma guidelines to assess asthma severity in populations. Eur Respir J 2000; 16: 615–620, [INFOTRIEVE], [CSA]
- Van Ganse E, Boissel J P, Gormand F, Ernst P. Level of asthma control and hospital contacts in persistent asthma. J Asthma 2001; 637–643, [CROSSREF], [CSA]
- Asthma in America Survey Executive Summary. SRBI. December, 1998, http//:www.asthmainamerica.com available at
- Children with Asthma in America. Oct., 2004, http//:www.asthmainamerica.com GR137820 available at
- Fuhlbrigge A L, Adams R J, Guilbert T W, et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the National Asthma Education and Prevention Program guidelines. Am J Respir Crit Care Med 2002; 166: 1044–1049, [INFOTRIEVE], [CROSSREF], [CSA]
- Murphy K R. Asthma: versatile treatment for a variable disease. J Asthma 2005; 42: 149–157, [INFOTRIEVE], [CSA]
- Calhoun W J, Sutton L B, Emmett A, et al. Asthma variability in patients previously treated with beta2-agonists alone. J Allergy Clin Immunol 2003; 112: 1085–1094, [CROSSREF], [CSA]
- Chipps B C, Spahn J D, Sorkness C A, Sutton L B, Dorinsky P M. Variability of asthma severity in pediatric subjects previously receiving short active beta-agonists-presented at American College. Allergy, Asthma, and Immunology Meeting, New Orleans, LA, November, 7–122003
- The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343: 1054–1063, [CROSSREF], [CSA]
- Pauwels R A, Pedersen S, Busse W W, Tan W C, Chen Y-Z, Ohlsson S V, Ullman A, Lamm C J, O'Byrne PM, on behalf of the START Investigators Group. Early intervention with budesonide in mild persistent asthma: a randomized, double-blind trial. Lancet 2003; 361: 1071–1076, [INFOTRIEVE], [CROSSREF], [CSA]
- Meyts I, Proesmans M, De Boeck K. Exhaled nitric oxide corresponds with office evaluation of asthma control. Pediatr Pulmonol 2003; 36: 283–289, [INFOTRIEVE], [CROSSREF], [CSA]
- Smith A D, Cowan J O, Brassett K P, Herbison G P, Taylor D R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352: 2163–2173, [INFOTRIEVE], [CROSSREF], [CSA]
- Bateman E D, Boushey H A, Bousquet J, Busse W W, Clark T JH, Pauwels R A, Pedersen SE for the GOAL Investigators Group. Can guideline-define asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 2004; 170: 836–844, [INFOTRIEVE], [CROSSREF], [CSA]
- Nathan R A, Sorkness C A, Kosinski M, et al. Development of the Asthma Control Test: a survey for assessing asthma control. J Allergy Clin Immunology 2004; 113: 59–65, [CROSSREF], [CSA]